Delivery Order SPE2DB24D2101-SPE2DB26FKFCF
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,951.86 to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with an ultimate completion date of September 16, 2025. This is a firm fixed price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Somatuline Depot 120 mg/0.5 mL pharmaceutical product. This firm fixed-price delivery order, valued at $3,951.86, represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025. The award is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $19,759.30 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceutical product. The contract, awarded on October 22, 2025, with an ultimate completion date of November 13, 2025, utilizes firm fixed price pricing under a non-competitive, non-set-aside arrangement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with performance completed by August 13, 2025. This non-set-aside, firm fixed-price contract was awarded competitively on July 23, 2025, with performance conducted at the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $39,518.60 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml pharmaceutical product, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $7,903.74 for Somatuline Depot 120 mg/0.5 ml on September 2, 2025, with completion targeted for September 23, 2025. The award is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,616.51 for Somatuline Depot 90 mg/0.3 ml pharmaceutical product on August 4, 2025, with completion targeted for August 25, 2025. This is a firm fixed price, non-set-aside delivery order to be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $47,422.32 to AmerisourceBergen Drug Corp for the supply of Somatuline Depot 120 mg/0.5 ml injectables. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 10, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's pharmaceutical supply services to support federal medical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Somatuline Depot 120 mg/0.5 ml injectable medication, with a contract ceiling value of $23,711.16. This is a firm fixed-price delivery order with no set-aside designation, demonstrating AmerisourceBergen's qualification to compete in open federal procurement. The order is scheduled for completion by October 7, 2025, and will be performed at the...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB26FKFCFDelivery Order
The Defense Logistics Agency awarded a $3,951.86 delivery order to AmerisourceBergen Drug Corp for Somatuline Depot 120 mg/0.5 ml pharmaceutical product on October 23, 2025, with an ultimate completion date of November 14, 2025. This delivery order, classified as firm fixed price with no set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award is issued as a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide, enabling the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities to procure a broad range of medications and medical commodities. AmerisourceBergen's position as a major pharmaceutical distributor and critical federal medical procurement vendor is reinforced through this ongoing partnership with DLA, which continues to rely on the company's capabilities to fulfill specialized pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/23/25 |